Patents by Inventor JEAN-YVES LANNE

JEAN-YVES LANNE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9757340
    Abstract: The present invention relates to pharmaceutical compositions intended to be used in the form of a solid unit such as a tablet, for oral administration, comprising a high content of fexofenadine and/or of at least one pharmaceutically acceptable salt thereof, and also to hot-melt processes for manufacturing solid units.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: September 12, 2017
    Assignee: SANOFI
    Inventors: Baptiste Merillon, Jean-Yves Lanne, Marie Renouard
  • Publication number: 20150313885
    Abstract: The present invention relates to pharmaceutical compositions intended to be used in the form of a solid unit such as a tablet, for oral administration, comprising a high content of fexofenadine and/or of at least one pharmaceutically acceptable salt thereof, and also to hot-melt processes for manufacturing solid units.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 5, 2015
    Inventors: Baptiste MERILLON, Jean-Yves LANNE, Marie RENOUARD
  • Patent number: 8535721
    Abstract: The subject of the invention is pharmaceutical microspheres containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: September 17, 2013
    Assignee: Sanofi-Synthelabo
    Inventors: Christian Langlois, Jean-Yves Lanne
  • Publication number: 20060263437
    Abstract: The subject of the invention is pharmaceutical microspheres containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures.
    Type: Application
    Filed: February 21, 2006
    Publication date: November 23, 2006
    Inventors: Christian Langlois, Jean-Yves Lanne
  • Publication number: 20030157177
    Abstract: The subject of the invention is pharmaceutical microspheres containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures.
    Type: Application
    Filed: October 15, 2002
    Publication date: August 21, 2003
    Applicant: Sanofi-Synthelabo, a corporation of France.
    Inventors: Christian Langlois, Jean-Yves Lanne
  • Publication number: 20020001598
    Abstract: The subject of the invention is pharmaceutical microspheres containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures.
    Type: Application
    Filed: July 23, 1999
    Publication date: January 3, 2002
    Inventors: CHRISTIAN LANGLOIS, JEAN-YVES LANNE